Skip to main content

Table 2 Baseline clinical and immunological status of Children on ART at Felege Hiwot referral hospital, January 1 st , 2006 - March 31 st , 2011

From: Predictors of mortality among children on Antiretroviral Therapy at a referral hospital, Northwest Ethiopia: A retrospective follow up study

Variable

Frequency

Percent (%)

ART eligibility criteria

  

  WHO clinical stage

 

9

1.6

  Immunological/CD4Count

 

35

6.4

  Both clinical and immunologic

 

505

92.0

Type of drug at initiation of therapy

  

  4a(d4T-3TC-NVP)

 

208

37.9

  4b(d4T-3TC-EFV)

 

37

6.7

  4c(AZT-3TC-NVP)

 

258

47.0

  4d(AZT-3TC-EFV)

 

43

7.8

  Kaletra based

 

3

0.6

Regimen change during follow up

  

  Yes

 

68

12.5

  No

 

475

87.5

Absolute CD4 count

  

  CD4 count below the threshold

 

289

52.6

  CD4 count above the threshold

 

260

47.4

Developmental History

  

  Appropriate

 

531

96.7

  Delayed

 

9

1.6

  Regressing

 

9

1.6

Cotrimoxazole preventive therapy

  

  Yes

 

287

52.3

  No

 

262

47.7

Nutritional status

  

  Underweight

 

453

82.5

  Normal

 

92

16.8

  Overweight

 

4

0.7

WHO clinical staging

  

  I

 

45

8.2

  II

 

128

23.3

  III

 

317

57.7

  IV

 

59

10.7

Haemoglobin(520)

  

  <10gm/dl

 

103

19.8

  ≥10gm/dl

 

417

80.2

3 rd month ART drug adherence (497)

  

  Good

 

491

98.8

  Fair

 

3

0.6

  Poor

 

3

0.6

OIs during follow up

  

  Yes

 

165

30.1

  No

 

384

69.9

Side effect during follow up(526)

  

  Yes

 

49

8.9

  No

 

477

86.9